Search

everythinglearnresearchcommunity

for

Search:↓

Children under 10 can experience hair thinning without hormone issues, and it may improve with treatment.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Genetic mutations can affect female sexual development, requiring personalized medical care.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

A man with both Klinefelter syndrome and primary hyperparathyroidism showed a rare combination of symptoms and genetic patterns.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.

Six genetic conditions are often linked to complete scalp hair loss in children.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

"D-CHRAMPS syndrome" is a newly identified condition with multiple severe symptoms.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Some skin diseases and their treatments can negatively affect male fertility.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Clomiphene citrate can reverse low hormone levels and symptoms in male runners with hypogonadotropic hypogonadism.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.